Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.7 TWD
463.29 M TWD
1.51 B TWD
46.92 M
About CH BIOTECH R&D CO LTD
Sector
CEO
Cho Chun Huang
Headquarters
Nantou
Website
Founded
2013
ISIN
TW0006534001
FIGI
BBG009H0MZV5
CH Biotech R&D Co., Ltd. engages in the research, development, and sales of biotech-based agrochemicals. Its products include Nutrient Efficiency, Stress Reduction, Plant Growth Promotion, Crop Fruit Quality, and Plant Derived Biotechnology. The company was founded by Cheng Pang Wu on November 29, 2013 and is headquartered in Nantou, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6534 is 80.5 TWD — it hasn't changed in the past 24 hours. Watch CH BIOTECH R&D CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange CH BIOTECH R&D CO LTD stocks are traded under the ticker 6534.
6534 stock has fallen by −0.62% compared to the previous week, the month change is a −3.94% fall, over the last year CH BIOTECH R&D CO LTD has showed a −0.62% decrease.
6534 reached its all-time high on Mar 1, 2024 with the price of 95.0 TWD, and its all-time low was 72.1 TWD and was reached on Sep 9, 2024. View more price dynamics on 6534 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6534 stock is 0.00% volatile and has beta coefficient of 0.09. Track CH BIOTECH R&D CO LTD stock price on the chart and check out the list of the most volatile stocks — is CH BIOTECH R&D CO LTD there?
Today CH BIOTECH R&D CO LTD has the market capitalization of 7.82 B, it has decreased by −0.12% over the last week.
Yes, you can track CH BIOTECH R&D CO LTD financials in yearly and quarterly reports right on TradingView.
CH BIOTECH R&D CO LTD is going to release the next earnings report on Feb 21, 2025. Keep track of upcoming events with our Earnings Calendar.
6534 net income for the last quarter is −91.96 M TWD, while the quarter before that showed 130.14 M TWD of net income which accounts for −170.66% change. Track more CH BIOTECH R&D CO LTD financial stats to get the full picture.
CH BIOTECH R&D CO LTD dividend yield was 5.08% in 2023, and payout ratio reached 85.87%. The year before the numbers were 5.15% and 80.93% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 164.00 employees. See our rating of the largest employees — is CH BIOTECH R&D CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CH BIOTECH R&D CO LTD EBITDA is 662.39 M TWD, and current EBITDA margin is 48.30%. See more stats in CH BIOTECH R&D CO LTD financial statements.
Like other stocks, 6534 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CH BIOTECH R&D CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CH BIOTECH R&D CO LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CH BIOTECH R&D CO LTD stock shows the sell signal. See more of CH BIOTECH R&D CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.